What drug class does meloxicam belong to?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Meloxicam Drug Class

Meloxicam is a nonsteroidal anti-inflammatory drug (NSAID) that belongs to the oxicam class and functions as a preferential COX-2 inhibitor. 1

Classification Details

Meloxicam is specifically categorized as a prescription nonselective NSAID in clinical practice guidelines, despite having preferential selectivity for cyclooxygenase-2 (COX-2) over COX-1 1. This classification is important because:

  • Chemical structure: It is an oxicam derivative (4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1-dioxide) 2

  • Mechanism: While it preferentially inhibits COX-2, it is not classified alongside the highly selective COX-2 inhibitors like celecoxib (Celebrex), which remains the only pure COX-2 inhibitor available in the U.S. market 1

  • Clinical positioning: Guidelines list meloxicam under "Prescription Nonselective" NSAIDs rather than with COX-2 inhibitors, reflecting its intermediate selectivity profile 1

Clinical Implications of This Classification

The distinction matters for cardiovascular and gastrointestinal risk stratification:

  • Meloxicam carries the standard NSAID black box warning for cardiovascular thrombotic events, myocardial infarction, and stroke 3
  • It shares the same GI bleeding risks as other nonselective NSAIDs, with annual rates of 32,000 hospitalizations and 3,200 deaths from NSAID-related GI bleeding in the U.S. 1
  • Its preferential COX-2 selectivity may offer some theoretical GI advantage over traditional NSAIDs, but it does not have the distinct risk profile of pure COX-2 inhibitors

In summary: Meloxicam is an NSAID of the oxicam chemical class with preferential (but not highly selective) COX-2 inhibition, classified clinically as a nonselective NSAID for prescribing and risk assessment purposes.

References

Guideline

nsaid prescribing precautions.

American family physician, 2009

Research

Meloxicam.

Profiles of drug substances, excipients, and related methodology, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.